BRIEF-Genentech says FDA approves Rituxan Hycela for subcutaneous injection in certain blood cancers
* FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers
Dec 16 Solon Eiendom ASA (formerly Bionor Pharma ASA) :
* Said on Thursday appointed Andreas Martinussen as Chief Executive Officer
* Appointed Tarjei Røise Warholm as Chief Financial Officer Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
AMSTERDAM, June 22 Mylan NV shareholders voted against the generic drugmaker's executive pay policy but re-elected the board at its annual meeting on Thursday despite a shareholder campaign in the wake of a scandal over high prices for its EpiPen emergency allergy treatment.
* Four Republican senators say they "not ready to vote" for bill